ERBB2 and breast carcinoma: Further biological evaluation of phaeocaulisin A and its analogs 21 and 50 against a panel of triple-negativeor HER2+ breast cancer cell lines identified 21 withan α-methylene γ-butyrolactone moiety as a promising leadcompound for further development.